Physician

Aleksandra Kraeher, MD

According to 2025 Medicare claims, Aleksandra Kraeher, MD (NPI: 1790744910) practices endocrinology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is ALEKSANDRA KRAEHER MD PA (NPI: 1497876973; TIN: 030530441) and primary practice location at 33458-4831.

Kraeher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 921 traditional Medicare patients, billed 4,162 HCPCS/CPT codes, and received $249,319 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,893 prescription claims across 771 beneficiaries totaling $2,417,015 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,016 claims. Open Payments data shows 97 records totaling $2,541. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $913,585 to $2,417,015. For DME billing, reported payments moved sharply higher in recent years, from $8,215 to $227,808.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	613	3,786	$182,488
2016	655	3,513	$186,183
2017	682	3,714	$195,108
2018	695	3,406	$186,469
2019	725	3,464	$184,575
2020	757	3,471	$205,793
2021	831	3,938	$259,601
2022	861	4,122	$247,841
2023	914	4,123	$257,486
2024	921	4,162	$249,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	476	4,644	$913,585
2016	532	5,200	$1,145,649
2017	552	5,301	$1,414,517
2018	558	5,112	$1,666,257
2019	593	5,234	$1,920,599
2020	646	5,455	$1,941,872
2021	715	5,108	$1,918,238
2022	725	4,848	$2,160,253
2023	763	4,855	$2,435,734
2024	771	4,893	$2,417,015

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	358	747	$21,232
2016	341	756	$29,134
2017	263	637	$22,153
2018	321	807	$81,164
2019	281	899	$118,124
2020	234	849	$113,156
2021	211	873	$105,966
2022	271	984	$126,354
2023	269	1,116	$178,617
2024	243	1,016	$227,781

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	130	150	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	871	2,037	$93
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	168	487	$26
83036	Hemoglobin a1c level	304	509	$10
82947	Blood glucose (sugar) level	337	804	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	724	30,129	$931,104
Mounjaro	Tirzepatide	359	12,632	$455,613
Jardiance	Empagliflozin	186	11,590	$217,126
Trulicity	Dulaglutide	64	3,238	$106,496
Synthroid	Levothyroxine Sodium	612	47,563	$68,693

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	103	740	$207,712
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	21	$6,416
E0784	External ambulatory infusion pump, insulin	Y	N/R	18	$5,702
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	15	15	$3,392
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	82	144	$3,138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$2,541	BETA BIONICS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aleksandra Kraeher, MD?

Tedicare shows public-source Medicare data for Aleksandra Kraeher, MD (NPI 1790744910), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleksandra Kraeher, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aleksandra Kraeher, MD?

Aleksandra Kraeher, MD is linked to ALEKSANDRA KRAEHER MD PA (billing NPI 1497876973) in the available physician profile data.

Does Aleksandra Kraeher, MD have Open Payments data?

Aleksandra Kraeher, MD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.